Interval between symptom onset and diagnosis of pediatric solid tumors

Bradley H Pollock, Jeffrey P. Krischer, Teresa J. Vietti

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

Lag time (the interval between symptom onset and diagnosis) was described for 2665 children with lymphoma or a solid tumor who participated in Pediatric Oncology Group therapeutic protocols from 1982 until 1988. Median lag time ranged from 21 days for neuroblastoma to 72 days for Ewing sarcoma. Significant differences in lag time were found among diagnostic groups (p<0.001), even after adjustment for age, gender, and race. Age was significantly associated with lag time for all diagnoses (p<0.05) except Hodgkin disease. Girls had increased lag times for non-Hodgkin lymphoma (p=0.02) but decreased lag times for Ewing sarcoma (p=0.02). Differences in lag time related to race were significant only for children with osteosarcoma (p=0.02), for which white children had longer lag times. Type of tumor and age were strongly associated with lag time. Within diagnostic groups, age, gender, and race failed to explain more than 16% of the variance in lag time, suggesting that other factors may play more prominent roles. Further study is necessary to identify these factors and to assess the relationship between lag time, stage of disease at diagnosis, and prognosis, especially before designing early-detection interventions for childhood cancer.

Original languageEnglish (US)
Pages (from-to)725-732
Number of pages8
JournalThe Journal of Pediatrics
Volume119
Issue number5
DOIs
StatePublished - 1991
Externally publishedYes

Fingerprint

Pediatrics
Neoplasms
Ewing's Sarcoma
Osteosarcoma
Hodgkin Disease
Neuroblastoma
Non-Hodgkin's Lymphoma
Lymphoma
Age Groups

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Interval between symptom onset and diagnosis of pediatric solid tumors. / Pollock, Bradley H; Krischer, Jeffrey P.; Vietti, Teresa J.

In: The Journal of Pediatrics, Vol. 119, No. 5, 1991, p. 725-732.

Research output: Contribution to journalArticle

Pollock, Bradley H ; Krischer, Jeffrey P. ; Vietti, Teresa J. / Interval between symptom onset and diagnosis of pediatric solid tumors. In: The Journal of Pediatrics. 1991 ; Vol. 119, No. 5. pp. 725-732.
@article{e5c8b1458bfc49bd9cd3eacda4c00f5f,
title = "Interval between symptom onset and diagnosis of pediatric solid tumors",
abstract = "Lag time (the interval between symptom onset and diagnosis) was described for 2665 children with lymphoma or a solid tumor who participated in Pediatric Oncology Group therapeutic protocols from 1982 until 1988. Median lag time ranged from 21 days for neuroblastoma to 72 days for Ewing sarcoma. Significant differences in lag time were found among diagnostic groups (p<0.001), even after adjustment for age, gender, and race. Age was significantly associated with lag time for all diagnoses (p<0.05) except Hodgkin disease. Girls had increased lag times for non-Hodgkin lymphoma (p=0.02) but decreased lag times for Ewing sarcoma (p=0.02). Differences in lag time related to race were significant only for children with osteosarcoma (p=0.02), for which white children had longer lag times. Type of tumor and age were strongly associated with lag time. Within diagnostic groups, age, gender, and race failed to explain more than 16{\%} of the variance in lag time, suggesting that other factors may play more prominent roles. Further study is necessary to identify these factors and to assess the relationship between lag time, stage of disease at diagnosis, and prognosis, especially before designing early-detection interventions for childhood cancer.",
author = "Pollock, {Bradley H} and Krischer, {Jeffrey P.} and Vietti, {Teresa J.}",
year = "1991",
doi = "10.1016/S0022-3476(05)80287-2",
language = "English (US)",
volume = "119",
pages = "725--732",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Interval between symptom onset and diagnosis of pediatric solid tumors

AU - Pollock, Bradley H

AU - Krischer, Jeffrey P.

AU - Vietti, Teresa J.

PY - 1991

Y1 - 1991

N2 - Lag time (the interval between symptom onset and diagnosis) was described for 2665 children with lymphoma or a solid tumor who participated in Pediatric Oncology Group therapeutic protocols from 1982 until 1988. Median lag time ranged from 21 days for neuroblastoma to 72 days for Ewing sarcoma. Significant differences in lag time were found among diagnostic groups (p<0.001), even after adjustment for age, gender, and race. Age was significantly associated with lag time for all diagnoses (p<0.05) except Hodgkin disease. Girls had increased lag times for non-Hodgkin lymphoma (p=0.02) but decreased lag times for Ewing sarcoma (p=0.02). Differences in lag time related to race were significant only for children with osteosarcoma (p=0.02), for which white children had longer lag times. Type of tumor and age were strongly associated with lag time. Within diagnostic groups, age, gender, and race failed to explain more than 16% of the variance in lag time, suggesting that other factors may play more prominent roles. Further study is necessary to identify these factors and to assess the relationship between lag time, stage of disease at diagnosis, and prognosis, especially before designing early-detection interventions for childhood cancer.

AB - Lag time (the interval between symptom onset and diagnosis) was described for 2665 children with lymphoma or a solid tumor who participated in Pediatric Oncology Group therapeutic protocols from 1982 until 1988. Median lag time ranged from 21 days for neuroblastoma to 72 days for Ewing sarcoma. Significant differences in lag time were found among diagnostic groups (p<0.001), even after adjustment for age, gender, and race. Age was significantly associated with lag time for all diagnoses (p<0.05) except Hodgkin disease. Girls had increased lag times for non-Hodgkin lymphoma (p=0.02) but decreased lag times for Ewing sarcoma (p=0.02). Differences in lag time related to race were significant only for children with osteosarcoma (p=0.02), for which white children had longer lag times. Type of tumor and age were strongly associated with lag time. Within diagnostic groups, age, gender, and race failed to explain more than 16% of the variance in lag time, suggesting that other factors may play more prominent roles. Further study is necessary to identify these factors and to assess the relationship between lag time, stage of disease at diagnosis, and prognosis, especially before designing early-detection interventions for childhood cancer.

UR - http://www.scopus.com/inward/record.url?scp=0025953784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025953784&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(05)80287-2

DO - 10.1016/S0022-3476(05)80287-2

M3 - Article

C2 - 1941378

AN - SCOPUS:0025953784

VL - 119

SP - 725

EP - 732

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 5

ER -